Myeloma Canada is committed to providing you with the most reliable, relevant and up-to-date information on the coronavirus COVID-19 and myeloma as possible. That’s why we created the COVID-19 & Myeloma InfoBulletin.

This week subjects included:

• Clinical Trials
   
• Tocilizumab improves significantly clinical outcomes of patients with moderate or severe COVID-19 pneumonia
   
• Coronavirus Patients Are Reporting Neurological Symptoms. Here’s What You Need to Know 
   
• Bonspiel physicians to donate plasma as part of clinical trial for possible COVID-19 treatment  
   
• COVID-19 & Myeloma Webinars

Click here to read more.